XellSmart’s Parkinson’s cell shot adds 5 good hours a day
XellSmart’s off-the-shelf XS411 lifted motor scores in nine patients, and its 30-person Phase II trial has finished enrolling. The nine people in XellSmart’s Phase I trial had lived with Parkinson’s for about ten years each. Their drugs wore off between doses; they sat at stages 3 to 4 on the Hoehn–
<p>XellSmart’s off-the-shelf XS411 lifted motor scores in nine patients, and its 30-person Phase II trial has finished enrolling. The nine people in XellSmart’s Phase I trial had lived with Parkinson’s for about ten years each. Their drugs wore off between doses; they sat at stages 3 to 4 on the Hoehn–</p>